Shares of Merck KGaA (OTCMKTS:MKGAF – Get Free Report) fell 7% during trading on Tuesday . The company traded as low as $162.5750 and last traded at $162.5750. 95 shares changed hands during mid-day trading, a decline of 85% from the average daily volume of 640 shares. The stock had previously closed at $174.7740.
Merck KGaA Trading Up 2.0%
The company has a market cap of $21.87 billion, a P/E ratio of 25.84 and a beta of 0.96. The stock’s 50-day moving average is $149.16 and its two-hundred day moving average is $144.55. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
See Also
- Five stocks we like better than Merck KGaA
- Shorting the Grid: Bloom Energy’s $25B AI Power Play
- SanDisk’s Volatility May Be Telling Bulls What They Want to Hear
- Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon
- 3 Dividend ETFs Built for Stability in a Volatile Market
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
